623 related articles for article (PubMed ID: 19884614)
1. Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease.
van Exel E; Eikelenboom P; Comijs H; Frölich M; Smit JH; Stek ML; Scheltens P; Eefsting JE; Westendorp RG
Arch Gen Psychiatry; 2009 Nov; 66(11):1263-70. PubMed ID: 19884614
[TBL] [Abstract][Full Text] [Related]
2. [The immune system and Alzheimer's disease].
van Exel E; Eikelenboom P; Comijs HC; Kurniawan C; Frölich M; Smit JH; Stek ML; Scheltens P; Eefsting JE; Westendorp RG
Tijdschr Psychiatr; 2011; 53(9):637-43. PubMed ID: 21898320
[TBL] [Abstract][Full Text] [Related]
3. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
[TBL] [Abstract][Full Text] [Related]
4. Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease.
Brickell KL; Steinbart EJ; Rumbaugh M; Payami H; Schellenberg GD; Van Deerlin V; Yuan W; Bird TD
Arch Neurol; 2006 Sep; 63(9):1307-11. PubMed ID: 16966510
[TBL] [Abstract][Full Text] [Related]
5. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.
Huang W; Qiu C; von Strauss E; Winblad B; Fratiglioni L
Arch Neurol; 2004 Dec; 61(12):1930-4. PubMed ID: 15596614
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
Olarte L; Schupf N; Lee JH; Tang MX; Santana V; Williamson J; Maramreddy P; Tycko B; Mayeux R
Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study.
Khachaturian AS; Corcoran CD; Mayer LS; Zandi PP; Breitner JC;
Arch Gen Psychiatry; 2004 May; 61(5):518-24. PubMed ID: 15123497
[TBL] [Abstract][Full Text] [Related]
8. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
[TBL] [Abstract][Full Text] [Related]
9. APOE and cytokines as biological markers for recovery of prevalent delirium in elderly medical inpatients.
Adamis D; Treloar A; Martin FC; Gregson N; Hamilton G; Macdonald AJ
Int J Geriatr Psychiatry; 2007 Jul; 22(7):688-94. PubMed ID: 17203511
[TBL] [Abstract][Full Text] [Related]
10. Variability of age at onset in siblings with familial Alzheimer disease.
Gómez-Tortosa E; Barquero MS; Barón M; Sainz MJ; Manzano S; Payno M; Ros R; Almaraz C; Gómez-Garré P; Jiménez-Escrig A
Arch Neurol; 2007 Dec; 64(12):1743-8. PubMed ID: 18071037
[TBL] [Abstract][Full Text] [Related]
11. APOE, vascular pathology, and the AD brain.
Yip AG; McKee AC; Green RC; Wells J; Young H; Cupples LA; Farrer LA
Neurology; 2005 Jul; 65(2):259-65. PubMed ID: 16043796
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
[TBL] [Abstract][Full Text] [Related]
13. Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease.
Mocali A; Cedrola S; Della Malva N; Bontempelli M; Mitidieri VA; Bavazzano A; Comolli R; Paoletti F; La Porta CA
Exp Gerontol; 2004 Oct; 39(10):1555-61. PubMed ID: 15501026
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 gene -511 CT polymorphism and the risk of Alzheimer's disease in a Polish population.
Klimkowicz-Mrowiec A; Marona M; Wołkow P; Maruszak A; Styczynska M; Barcikowska M; Zekanowski C; Szczudlik A; Slowik A
Dement Geriatr Cogn Disord; 2009; 28(5):461-4. PubMed ID: 19940477
[TBL] [Abstract][Full Text] [Related]
15. TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels.
Laws SM; Perneczky R; Wagenpfeil S; Müller U; Förstl H; Martins RN; Kurz A; Riemenschneider M
Hum Mutat; 2005 Jul; 26(1):29-35. PubMed ID: 15895461
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-1 and risk of late-onset Alzheimer's disease: findings from a family study.
van Exel E; Eikelenboom P; Comijs H; Deeg DJ; Stek ML; Westendorp RG
Neurobiol Aging; 2014 Mar; 35(3):725.e7-10. PubMed ID: 24054991
[TBL] [Abstract][Full Text] [Related]
17. Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease.
Beyer K; Lao JI; Latorre P; Ariza A
Ann N Y Acad Sci; 2005 Dec; 1057():260-78. PubMed ID: 16399900
[TBL] [Abstract][Full Text] [Related]
18. Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease.
Yao L; Li K; Zhang L; Yao S; Piao Z; Song L
Brain Res; 2009 Sep; 1291():133-9. PubMed ID: 19631630
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia.
Bartzokis G; Lu PH; Geschwind DH; Edwards N; Mintz J; Cummings JL
Arch Gen Psychiatry; 2006 Jan; 63(1):63-72. PubMed ID: 16389198
[TBL] [Abstract][Full Text] [Related]
20. Variability of familial risk of Alzheimer disease across the late life span.
Silverman JM; Ciresi G; Smith CJ; Marin DB; Schnaider-Beeri M
Arch Gen Psychiatry; 2005 May; 62(5):565-73. PubMed ID: 15867110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
